This job aid offers providers a quick reference guide to screening and staging syphilis.
This algorithm will support providers in staging and treatment for early primary, secondary, and early latent syphilis.
This job aid offers providers a quick reference guide to syphilis treatment.
This algorithm assists providers in treating clients considered to have late latent syphilis (>1 year duration) or syphilis of unknown duration.
This patient information resource can be offered to clients who are interested in or who have been prescribed Doxy PEP as a post-exposure prophylaxis to prevent the acquisition of gonorrhea, chlamydia, and syphilis.
Title X agencies should have all patient-facing materials, such as the handout above, reviewed and adapted by their Informational & Educational (I&E) Advisory Committee. Learn more about I&E Materials Review.
This job aid supports providers in counseling, prescribing, and monitoring Doxy PEP as a post-exposure prophylaxis to prevent the acquisition of gonorrhea, chlamydia, and syphilis.
This algorithm assists providers in screening for syphilis starting with an initial nontreponemal test (e.g., Venereal Disease Research Laboratory [VDRL] or rapid plasma reagin [RPR] test) then confirming positive results with a reflex treponemal antibody detection test (e.g., fluorescent treponemal antibody absorbed [FTA-ABS] test, chemoluminescence immunoassays [CIA], enzyme immunoassays [EIA], or T pallidum particle agglutination [TP-PA] test).
This algorithm assists providers in screening for syphilis, starting with an initial automated treponemal test (e.g., fluorescent treponemal antibody absorbed [FTA-ABS] test, chemoluminescence immunoassays [CIA], enzyme immunoassays [EIA], or T pallidum particle agglutination [TP-PA] test) and then confirming positive results with a reflex nontreponemal test (e.g., Venereal Disease Research Laboratory [VDRL] or rapid plasma reagin [RPR] test).
As part of the Combatting Congenital Syphilis trilogy, the CTC-SRH speaks with Louisiana Department of Health's Michael Carter, a regional STD Control manager, and Ariel Johnson, a disease intervention specialist (DIS)/contact tracer, about their role in addressing syphilis and HIV and how clinicians and DIS can leverage relationships to help their communities.
The Centers for Disease Control and Prevention (CDC) recently released Clinical Guidelines on the Use of Doxycycline Postexposure Prophylaxis for Bacterial Sexually Transmitted Infection Prevention on June 6, 2024. This report is the first to outline the CDC's recommendation for the use of doxycycline postexposure prophylaxis (doxy PEP).
Learn more by watching our recorded DIALS from November 2023. Dr. Hilary Reno's slides outline the evidence base for doxy PEP.
In this DIALS, recorded on May 17th, 2024, Dr. Amanda Morgan and Dr. Cheryl Radeloff discuss the current state of sex work in the US, cover priority health needs and strategies for meeting unmet needs of sex workers, and discuss client-led counseling and education approaches for people involved in sex work.
In response to the rising rates of congenital syphilis infections, the CTC-SRH speaks with Dr. Kate Miele from the Centers for Disease Control and Prevention to review conventional testing and treatment protocols for syphilis.
In response to the rising rates of congenital syphilis infections, the CTC-SRH's own Associate Director, Tammy Bennett, will be discussing point-of-care testing and same-day treatment for syphilis infections and how Title X sites can implement these services in their own clinics.
In this DIALS, recorded on 1/9/2024, Sarah Diemert provided an overview of the American Society for Colposcopy and Cervical Pathology (ASCCP) mobile app and went through case studies using the app to determine appropriate next steps for various pap smear results. She also provided an overview of the guidelines most commonly followed in the United States, published by ASCCP, the American College of Obstetrics and Gynecologists (ACOG), the American Cancer Society (ACS), and the United States Preventive Services Task Force (USPSTF).
In this DIALS, recorded on 11/27/23, Dr. David Turok and Dr. Hilary Reno discussed emerging research that supports emergency contraception and post-exposure prophylaxis for sexually transmitted infections, including HIV. Studies have shown that PEP and EC are appropriate for prophylaxis following unprotected intercourse. Additionally, doxy PEP shows promise as a preventive measure for gonorrhea, chlamydia, and syphilis.
This DIALS, recorded on 8/30/2023, featured Stephanie Arnold Pang and Dr. Joseph Cherabie. It provides an overview of Expedited Partner Therapy and the strategies to mitigate legal, medical, practical, and administrative barriers to its implementation.
In this DIALS, recorded on 2/1/2023, guests Dr. Ina Park and Jessica Zamora discuss self-collected, in-home STI testing. Dr. Park focuses on the evidence around the technology used in in-home test kits and Ms. Zamora covers results and future directions for a pilot program for in-home STI testing launched by the National Coalition of STD Directors in early 2022.
The NCTCFP talks with Dr. Lindley Barbee, a faculty member at the University of Washington School of Medicine and medical director at the Public Health Seattle and King County STD Clinic, to talk about the nationwide rising rates of congenital syphilis, and how clinicians can prevent cases in their work.
This DIALS, recorded on 6/23/2022 with guest Brandi Howard, provides an overview of Phexxi vaginal gel, including effectiveness in pregnancy prevention, user satisfaction, and other characteristics. Phexxi for STI prevention is also discussed.
This DIALS was recorded 6/21/22 with guests Beth Kruse, MS, CNM, ARNP, Lead Clinician for the Family Planning Program of Public Health Seattle-King County, and Tammy Bennett, RN, MSN, WHNP-BC, DNP(s), Reproductive Health Statewide Nurse Consultant for Louisiana. This DIALS focuses on an in-depth discussion of tailored public health strategies aimed at addressing missed opportunities and closing disparities gaps for the prevention of congenital syphilis in the family planning setting.
In this archived webinar, recorded on April 28, 2022, Dr. Ina Park presents the latest updates in STI Treatment Guidelines.
After watching this 1 hour webinar, viewers should be able to:
Please note: CE is no longer available for this webinar.
The NCTCFP sits down with Dr. Hilary Reno from Washington University School of Medicine to discuss STIs, PID, and infertility in recognition of Infertility Awareness Month and STI Awareness Week.
CDC's Sexually Transmitted Infections (STI) Treatment Guidelines, 2021 provides current evidence-based prevention, diagnostic and treatment recommendations that replace the 2015 guidance. The recommendations are intended to be a source for clinical guidance.
The NCTCFP sits down with Dr. Hilary Reno, Assistant Professor at Washington University School of Medicine in Infectious Diseases in St. Louis, to discuss the treatment guidelines for gonorrhea released by the CDC in an MMWR in December 2020.
In this episode, Ann Finn discusses codes to use when seeing a patient and billing for Post-Exposure Prophylaxis (PEP) for HIV prevention.
Listen to this podcast for free on our website using the players above, downloading it to your computer, or stream on your phone by searching for The Family Planning Files on your favorite podcast app.
The NCTCFP speaks with Dr. Ina Park, from UCSF School of Medicine, about current rates of syphilis in the US, including congenital and neurosyphilis. The first of a three-part series. This podcast series is funded by an award from the US DHHS Office of Population Affairs. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of HHS, OASH, or OPA. A transcript of the podcast is available below.
The NCTCFP speaks with Dr. Ina Park, from UCSF School of Medicine, about the signs and symptoms of syphilis in all stages of infection, and how they can aid clinicians in staging and diagnosis. The second of a three-part series. This podcast series is funded by an award from the US DHHS Office of Population Affairs. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of HHS, OASH, or OPA. A transcript of the podcast is available below.
The NCTCFP speaks with Dr. Ina Park, from UCSF School of Medicine, about the CDC recommended testing and treatment guidelines for syphilis infections in all stages. The third of a three-part series. This podcast series is funded by an award from the US DHHS Office of Population Affairs. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of HHS, OASH, or OPA. A transcript of the podcast is available below.
During this episode, we welcome back Dr. Bradley Stoner, MD, PhD, to discuss the latest data and trends regarding sexually transmitted infections in the United States. Dr. Stoner is the Medical Director at the St. Louis STD/HIV Prevention Training Center, an associate professor at Washington University School of Medicine, and past president of the American Sexually Transmitted Diseases Association. This podcast series is funded by an award from the US DHHS Office of Population Affairs. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of HHS, OASH, or OPA. A transcript is available below.
In this episode, Ann Finn will review codes that can be used for billing STD and HIV screenings. This podcast series assists family planning providers with appropriate and timely reimbursement. A copy of the transcript is below.
Our guest speaker, Dr. Bradley Stoner, discusses the latest STD trends and treatment in the United States. Dr. Stoner is the Medical Director of the St. Louis STD/HIV Prevention Training Center, and is an Associate Professor of Anthropology and Medicine at Washington University School of Medicine in St. Louis, Missouri.
